These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22954333)

  • 1. Fluorogenic quantum dot-gold nanoparticle assembly for beta secretase inhibitor screening in live cell.
    Choi Y; Cho Y; Kim M; Grailhe R; Song R
    Anal Chem; 2012 Oct; 84(20):8595-601. PubMed ID: 22954333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplified voltammetric characterization of cleavage of the biotinylated peptide by BACE1 and screening of BACE1 inhibitors.
    Yi X; Han H; Zhang Y; Wang J; Zhang Y; Zhou F
    Biosens Bioelectron; 2013 Dec; 50():224-8. PubMed ID: 23867352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived β-secretase inhibitors.
    Wood S; Wen PH; Zhang J; Zhu L; Luo Y; Babu-Khan S; Chen K; Pham R; Esmay J; Dineen TA; Kaller MR; Weiss MM; Hitchcock SA; Citron M; Zhong W; Hickman D; Williamson T
    J Pharmacol Exp Ther; 2012 Nov; 343(2):460-7. PubMed ID: 22911925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticle-quantum dot-polystyrene microspheres as fluorescence resonance energy transfer probes for bioassays.
    Quach AD; Crivat G; Tarr MA; Rosenzweig Z
    J Am Chem Soc; 2011 Feb; 133(7):2028-30. PubMed ID: 21280652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surface plasmon resonance-based biosensor with full-length BACE1 in a reconstituted membrane.
    Christopeit T; Stenberg G; Gossas T; Nyström S; Baraznenok V; Lindström E; Danielson UH
    Anal Biochem; 2011 Jul; 414(1):14-22. PubMed ID: 21382336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors.
    Shi L; Rosenzweig N; Rosenzweig Z
    Anal Chem; 2007 Jan; 79(1):208-14. PubMed ID: 17194141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-dependent network formation of quantum dots and fluorescent quenching by Au nanoparticle embedding.
    Sekiguchi S; Niikura K; Iyo N; Matsuo Y; Eguchi A; Nakabayashi T; Ohta N; Ijiro K
    ACS Appl Mater Interfaces; 2011 Nov; 3(11):4169-73. PubMed ID: 21970588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay.
    Xu W; Chen G; Liew OW; Zuo Z; Jiang H; Zhu W
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3188-92. PubMed ID: 19447035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition assay of biomolecules based on fluorescence resonance energy transfer (FRET) between quantum dots and gold nanoparticles.
    Oh E; Hong MY; Lee D; Nam SH; Yoon HC; Kim HS
    J Am Chem Soc; 2005 Mar; 127(10):3270-1. PubMed ID: 15755131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stereoselective approach to peptidomimetic BACE1 inhibitors.
    Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
    Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
    Cheng Y; Judd TC; Bartberger MD; Brown J; Chen K; Fremeau RT; Hickman D; Hitchcock SA; Jordan B; Li V; Lopez P; Louie SW; Luo Y; Michelsen K; Nixey T; Powers TS; Rattan C; Sickmier EA; St Jean DJ; Wahl RC; Wen PH; Wood S
    J Med Chem; 2011 Aug; 54(16):5836-57. PubMed ID: 21707077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors.
    Clapp AR; Medintz IL; Mauro JM; Fisher BR; Bawendi MG; Mattoussi H
    J Am Chem Soc; 2004 Jan; 126(1):301-10. PubMed ID: 14709096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
    Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant beta-secretase immobilized enzyme reactor for fast hits' selection and characterization from a virtual screening library.
    De Simone A; Mancini F; Cosconati S; Marinelli L; La Pietra V; Novellino E; Andrisano V
    J Pharm Biomed Anal; 2013 Jan; 73():131-4. PubMed ID: 22502908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo.
    Atwal JK; Chen Y; Chiu C; Mortensen DL; Meilandt WJ; Liu Y; Heise CE; Hoyte K; Luk W; Lu Y; Peng K; Wu P; Rouge L; Zhang Y; Lazarus RA; Scearce-Levie K; Wang W; Wu Y; Tessier-Lavigne M; Watts RJ
    Sci Transl Med; 2011 May; 3(84):84ra43. PubMed ID: 21613622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of a concentric Förster resonance energy transfer relay on a quantum dot scaffold: characterization and application to multiplexed protease sensing.
    Algar WR; Ancona MG; Malanoski AP; Susumu K; Medintz IL
    ACS Nano; 2012 Dec; 6(12):11044-58. PubMed ID: 23215458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
    J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
    Hamada Y; Suzuki K; Nakanishi T; Sarma D; Ohta H; Yamaguchi R; Yamasaki M; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2014 Jan; 24(2):618-23. PubMed ID: 24360554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.